AB&B BIOTECH
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
AB&B BIOTECH
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
Taizhou, Jiangsu, China
Country:
China
Website Url:
http://www.abbbio.com
Status:
Active
Contact:
0523-82205899
Email Addresses:
[email protected]
Total Funding:
92.73 M USD
Investors List
Qiandao Fund
Qiandao Fund investment in Series C - Ab&B Biotech
Sanhua Hongdao Investment
Sanhua Hongdao Investment investment in Series C - Ab&B Biotech
CS Capital
CS Capital investment in Series C - Ab&B Biotech
Puxin Capital
Puxin Capital investment in Series C - Ab&B Biotech
Green Pine Capital Partners
Green Pine Capital Partners investment in Series C - Ab&B Biotech
Official Site Inspections
http://www.abbbio.com
- Host name: 123.59.154.172
- IP address: 123.59.154.172
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
More informations about "Ab&B Biotech"
About Us_Tetravalent influenza virus subunit vaccine (adult
About Us-Tetravalent influenza virus subunit vaccine (adult type)，child type，Ab&B Bio-Tech CO.,LTD.JSAb&B Bio-Tech CO.,LTD.JS was incorporated in China Medical City, Taizhou City, …See details»
Ab&B Biotech - Crunchbase Company Profile & Funding
Organization. Ab&B Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; …See details»
公司介绍-江苏中慧元通生物科技股份有限公司 - Ab&B …
江苏中慧元通生物科技股份有限公司注册资金3.6亿元人民币，总占地面积173亩，总建筑面积19.8万平方米。其中一号生产园区占地面积69亩，建筑面积5万平方，项目投资10亿元人民币；二号生产园区占地面积72亩，建筑面积12万平方 …See details»
大事记-江苏中慧元通生物科技股份有限公司 - Ab&B Bio
江苏中慧元通生物科技股份有限公司在江苏省泰州市中国医药城注册成立，注册资本3.6亿元人民币，项目总投资36亿元人民币，总占地面积173亩，下属全资子公司——易慧生物技术（上海）有限公司成立于2020年，位于上海市浦东新区张 …See details»
AB&B BIO-TECH - PharmaSource
AB&B BIO-TECH is a professional company dedicated to the research, development, production, and sales of human vaccines. With registered capital of 125 million RMB, the…See details»
Product Center - Ab&B Bio
Product Center-Tetravalent influenza virus subunit vaccine (adult type)，child type，Ab&B Bio-Tech CO.,LTD.JSAb&B Bio-Tech CO.,LTD.JS was incorporated in China Medical City, …See details»
Jiangsu Zhonghui Yuantong Biological Technology Co., Ltd.
了解Jiangsu Zhonghui Yuantong Biological Technology Co., Ltd. (江苏中慧元通生物科技股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的10项临床试验, 43篇新闻，疾病领域: …See details»
Pharmaceutical Research & Development
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's livesSee details»
Product Center - Ab&B Bio
Currently, Phase III clinical trial has been completed and NDA production approval is pending. This product covers four influenza virus strains recommended by the World Health …See details»
Product Center - Ab&B Bio
May 8, 2023 Categories: Company news Author: Origin: Time of issue: 2023-05-08 Views: (Summary description) Since May 2022, the global epidemic of monkeypox virus has attracted public attention to the threat of human zoonotic …See details»
企业文化-江苏中慧元通生物科技股份有限公司 - Ab&B Bio
江苏中慧元通生物科技股份有限公司在江苏省泰州市中国医药城注册成立，注册资本3.6亿元人民币，项目总投资36亿元人民币，总占地面积173亩，下属全资子公司——易慧生物技术（上海） …See details»
2024-2025流感季慧尔康欣获批签上市-江苏中慧元通生物科技股份 …
Jun 12, 2024 江苏中慧元通生物科技股份有限公司在江苏省泰州市中国医药城注册成立，注册资本3.6亿元人民币，项目总投资36亿元人民币，总占地面积173亩，下属全资子公司——易慧生 …See details»
About ABB - ABB Group
Building on over 140 years of excellence, our more than 105,000 employees worldwide are committed to delivering on our purpose with innovations that create success for ABB and all …See details»
2024-2025 Flu Season HRK-X Approved for Signing On
Jun 12, 2024 The World Health Organization Influenza Vaccine Position Paper (2022 Edition) and the China Influenza Vaccination Technical Guidelines (2023-2024) both point out that …See details»
江苏中慧元通生物科技股份有限公司 - 爱企查
简介： 1、基本情况 江苏中慧元通生物科技股份有限公司是一家瞪羚企业(2023)、中国疫苗行业协会会员、民营科技企业，该公司成立于2015年10月28日，位于泰州市医药高新区杏林路32 …See details»
News_News_Tetravalent influenza virus subunit vaccine (adult type ...
Aug 14, 2024 Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio）has received acceptance from the Drug Evaluation Center (CDE) of the China National Medical Products Administration for its …See details»
Quadrivalent Subunit Influenza Vaccine（0.5ml） - Ab&B Bio
Quadrivalent Subunit Influenza Vaccine（0.5ml）-Tetravalent influenza virus subunit vaccine (adult type)，child type，Ab&B Bio-Tech CO.,LTD.JS-This strain is made by inoculating …See details»
流感病毒亚单位疫苗（佐剂）IND申请获批 - abbbio.com
Oct 30, 2024 近日，江苏中慧元通生物科技股份有限公司（以下简称“中慧生物”）与子公司易慧生物技术（上海）有限公司（以下简称“易慧生物”）联合申报的一类新药“流感病毒亚单位疫苗（ …See details»
三价流感病毒亚单位疫苗上市申请获得受理！ - abbbio.com
Oct 8, 2024 近日，江苏中慧元通生物科技股份有限公司（以下简称“中慧生物”）申报的“6-35月龄三价流感病毒亚单位疫苗”、“3岁及以上人群三价流感病毒亚单位疫苗”上市申请均获得中国国 …See details»